That the Indian health policy is full of flip-flops and uncertainties is a given. The sector falls under the purview of two different ministries (the Ministry of Chemicals and Fertilizers and the Ministry of Health and Family Welfare) and this leads to confusion on who regulates what. This lack of a common agenda for the […]Read More The Uncertainty of Drug Regulation in India
What if clinical trials don’t happen in India? Indian patients will continue to be treated with existing standard of stagnating care. The world would have moved on to better medicines buoyed by innovation. But Indian patients will need to be excluded from this wave of change for the better. The Drugs Controller General of India (DCGI)’s […]Read More What if clinical trials don’t happen in India?
On Jan 30, 2013 while the country stood in silence as a mark of respect to the father of the nation on his 65th death anniversary, a gazette notification was passed which could mean the death of good quality serious clinical research in India. It definitely means the death of reasoning, the death of stakeholder […]Read More What are we compensating for?
In Munnabhai MBBS Boman Irani, as Dean of a Medical College, tells medical students on their first day, that doctors need to be clinical. He meant that as a doctor one cannot be too close to a patient as this can reduce objectivity and come in the way of sound clinical decision-making. So what does […]Read More Being clinical with rhetoric